| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |